Hamburg Says Generic Drug Reviews Would Slow In Wake Of GOP-Backed Budget Cuts
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA commissioner predicts poor outlook for medical product review if agency loses appropriations in fiscal 2011 and 2012.